Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs State Street Technology Select Sector SPDR ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while State Street Technology Select Sector SPDR ETF trades at $187.4 (market cap $129.38B). The key difference: State Street Technology Select Sector SPDR ETF is far larger — about 4.2× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while State Street Technology Select Sector SPDR ETF pays none. Which is the better fit depends on your goals.
| GEHC | XLK | |
|---|---|---|
Market Cap | $30.93B | $129.38B |
Volume | 5,033,451 | 11,921,254 |
Sector | Health | Sector/Thematic |
52-Week High | $88.16 | $202.00 |
52-Week Low | $59.48 | $127.49 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 50 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
XLK trades at $196.24, showing minimal daily movement with a slight decline of 0.06%. The technical outlook is bullish based on moving averages, while oscillators remain neutral. Recent news highlights concentration concerns in XLK's holdings despite its technology sector focus. The ETF approaches key resistance levels with support established at $195.
The ETF faces concentration risks in semiconductor holdings, but technology sector strength and AI-driven demand provide growth catalysts. Key risks include interest rate sensitivity and sector rotation pressures. Analyst sentiment remains mixed with technical indicators favoring cautious optimism near-term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About State Street Technology Select Sector SPDR ETF
XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →
